Stonington Capital Appreciation 1994 Fund L P

Avg. Two Year Performance

No purchase track record

(39%) Avg. Sale Return

(18%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(17%)	(16%)	< 1%	(3%)	(39%)
Sale Success Rate	0 of 1	0 of 1	1 of 1	0 of 1	0 of 1

Obagi Medical Products, Inc.

Drugs » Biotechnology

10% Owner:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--